Global Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) Therapeutics Pipeline Report 2016 - Review of 5 Companies & Drug Profiles - Research and Markets

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) Overview
3. Therapeutics Development
4. Pipeline Products for Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Overview
5. Pipeline Products for Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Comparative Analysis
6. Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Therapeutics under Development by Companies
7. Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Therapeutics under Investigation by Universities/Institutes
8. Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Products under Development by Companies
13. Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Products under Investigation by Universities/Institutes
14. Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Companies Involved in Therapeutics Development

• Applied Genetic Technologies Corporation
• bluebird bio, Inc.
• Minoryx Therapeutics s.l.
• ReceptoPharm, Inc.
• Viking Therapeutics, Inc.

For more information visit http://www.researchandmarkets.com/research/qf2lkq/adrenoleukodystrop

View source version on businesswire.com: http://www.businesswire.com/news/home/20160629005901/en/